The cancer diagnostics industry is expected to experience significant growth in the near future as a result of technological advances, such as artificial intelligence (AI) and machine learning (ML). AI and ML are already being used to detect cancer in its early stages, helping to increase the accuracy and reduce the cost of cancer diagnostics. Additionally, advancements in genomics, biomarkers, and imaging technologies are providing more accurate and reliable methods for cancer diagnosis. Furthe...

The Global Cancer Diagnostics Market in terms of revenue was estimated to be worth $17.2 billion in 2021 and is poised to reach $26.6 billion by 2026, growing at a CAGR of 11.5% from 2021 to 2026. Growth of the market is driven mainly by increasing incidence of cancer and growth in the number of private diagnostic laboratories. Key Market Players: Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US.), F. Hoffman-La Roche AG (Switzerland), QIAGEN...